DSIP 10mg (Delta Sleep-Inducing Peptide) Lab Grade Research Peptide — 99%+ Purity

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide originally discovered in the 1970s through investigation of neurobiological sleep factors. DSIP is studied extensively for its role in regulating sleep-wake cycles, promoting slow-wave (delta) sleep, reducing stress, and supporting circadian rhythm adaptation. This DSIP 10mg lyophilized research peptide is a valuable tool for preclinical investigations of sleep physiology, stress resilience, and neuroendocrine regulation in research models.

What Is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring 9-amino-acid neuropeptide discovered through investigations of sleep-regulating factors in mammalian cerebrospinal fluid. The peptide was identified by Russian researchers who isolated it from the blood of sleep-deprived animals and demonstrated its ability to promote slow-wave sleep and increase delta-band EEG activity—the hallmark of deep, restorative sleep. DSIP represents a key endogenous sleep factor, with research suggesting it acts through multiple neuroendocrine and neurochemical pathways to modulate sleep architecture, stress responses, and circadian function.

DSIP Mechanisms of Action

DSIP operates through diverse neurobiological mechanisms to regulate sleep and stress physiology. The peptide activates specific receptors and signaling pathways in the hypothalamus, limbic system, and brainstem nuclei involved in sleep-wake regulation and arousal control. Key mechanisms include enhancement of GABAergic (inhibitory) neurotransmission, modulation of serotonergic and dopaminergic tone, regulation of hypocretin/orexin signaling (which controls arousal), and modulation of corticotropin-releasing factor (CRF) and stress hormone pathways. DSIP also influences melatonin secretion and circadian pacemaker function, supporting synchronized sleep-wake cycles. Additionally, DSIP exhibits neuroprotective and anti-inflammatory properties independent of its sleep-promoting effects, affecting neuroinflammatory signaling and cellular stress responses.

DSIP Research Applications

Preclinical and translational research documents DSIP investigation for:

• Sleep-wake regulation and sleep architecture
• Slow-wave (delta) sleep promotion and EEG power
• Sleep quality and restorative sleep processes
• Stress reduction and HPA axis regulation
• Circadian rhythm entrainment and adaptation
• Insomnia and sleep disorder models
• Anxiety and stress resilience
• Neuroimmune and inflammatory pathways
• Neuroprotection and neuroinflammation
• Aging-related sleep deterioration
• Cognitive function and memory consolidation (sleep-dependent)
• Recovery from physical and psychological stress

DSIP Sleep Physiology

Sleep is divided into rapid-eye-movement (REM) and non-REM stages; non-REM sleep is further divided into N1, N2, and N3. Stage N3, characterized by high-amplitude slow waves (0.5–4 Hz, delta band), is called slow-wave sleep (SWS) and is considered the most restorative sleep phase. During SWS, the brain consolidates declarative (factual) memories, clears metabolic waste products, restores immune function, and regulates metabolic homeostasis. DSIP is specifically investigated for its ability to deepen and prolong SWS, increasing delta-band EEG power and enhancing these restorative processes. Reduced SWS is associated with cognitive decline, metabolic disorders, immune dysfunction, and poor stress resilience in aging and disease models—making DSIP a relevant research target for understanding sleep-health relationships.

DSIP and Stress Physiology

The hypothalamic-pituitary-adrenal (HPA) axis orchestrates stress responses through corticotropin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), and glucocorticoids (cortisol/corticosterone). Chronic stress dysregulates this system, leading to sleep disturbance, anxiety, impaired immunity, and metabolic dysfunction. DSIP research demonstrates modulation of HPA axis tone and CRF signaling, promoting parasympathetic dominance and reducing HPA hyperactivity. This stress-buffering action is independent of sleep promotion and suggests DSIP acts as an endogenous anxiolytic and stress-resilience factor. Investigator-initiated studies examine DSIP for recovery from acute and chronic stress exposure.

DSIP Specifications

Compound	DSIP (Delta Sleep-Inducing Peptide, 9-amino-acid neuropeptide)
Quantity	10mg per vial (lyophilized)
Form	Lyophilized powder
Purity	≥99% (HPLC verified)
Sequence	9-amino-acid neuropeptide
Molecular Weight	Available on COA
Storage	-20°C (lyophilized); 2-8°C (reconstituted)
CAS Number	Available on COA
Appearance	White to off-white lyophilized powder
Packaging	Sealed sterile glass vial

Quality Verification

• HPLC purity verification (≥99%)
• Mass spectrometry sequence and identity confirmation
• Amino acid composition analysis
• Endotoxin and microbial contamination testing
• Certificate of Analysis (COA) included with every order

Reconstitution & Handling

DSIP 10mg is reconstituted with bacteriostatic water for laboratory research. Add the diluent slowly down the inside wall of the vial to ensure complete dissolution without foaming. Once reconstituted, store the solution at 2-8°C and protect from light. Prepare aliquots to avoid repeated freeze-thaw cycles. Always follow institutional protocols for peptide handling, storage, and documentation in compliance with research regulations.

Frequently Asked Questions

What is DSIP and what does it do?

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide that promotes slow-wave sleep and enhances delta-band EEG activity. It also modulates stress responses, circadian rhythms, and has neuroprotective properties through multiple neurobiological pathways.

How does DSIP promote sleep?

DSIP enhances GABAergic (inhibitory) neurotransmission, modulates arousal-promoting systems (hypocretin/orexin), reduces HPA axis stress signaling, and directly increases slow-wave sleep (delta band EEG). It also supports melatonin secretion and circadian synchronization.

What is the purity of CoreVionRX DSIP?

CoreVionRX DSIP 10mg is ≥99% purity, verified by HPLC and confirmed by mass spectrometry. Sequence identity and amino acid composition are verified. Each batch includes a Certificate of Analysis documenting purity, molecular weight, and sterility testing.

How should DSIP be stored and reconstituted?

Store the lyophilized vial at -20°C for maximum stability. Reconstitute with bacteriostatic water by adding slowly down the vial wall. After reconstitution, store at 2-8°C, protect from light, and prepare small aliquots to avoid freeze-thaw cycles.DSIP is supplied strictly for laboratory and research use only. Not for human or animal consumption.